INTRODUCTION
of case reports and case-series dealing with IRIS [3, 4] and the name IRD was given for the phenomenon Antiretroviral therapy (ART) strengthens the immune prior to 2000. [5] Joseph A. De Simone and colleagues system and restores protective pathogen-specific from Thomas Jefferson University in Philadelphia were immune responses. This results in decreased incidence one of the first groups who attempted to define of opportunistic infections (OI), decrease in the viral immune reconstitution syndrome in 2000. [6] load and increase in the CD4 counts. With restoration found that many HIV-positive people developed a of immunity, the body begins to fight aggressively spectrum of illnesses once they responded to HAART against coexisting infection thereby causing atypical They developed conditions such as Mycobacterium manifestations of opportunistic infections, which may avium complex (MAC) infection and cryptococcal cause severe inflammation in tissue. The constellation meningitis, at a time when their immune function of clinical symptoms, signs or investigational was actually improving. Initially it was considered to parameters resulting from such inflammatory response be a Jarisch-Herxheimer or lepra-like reaction. Later has been variously called immune reconstitution it was found to be due to the restoration of immunity inflammatory syndrome (IRIS) or immune restoration thereby eliciting hypersensitivity reaction to an disease (IRD) or immune rebound illness. [1] existing microbe or antigen in the body. De Simone and his colleagues named this relatively uncommon IRIS is defined as occurrence or worsening of clinical phenomenon as immune reconstitution syndrome. [6] and/or laboratory parameters despite a favorable They . outcome in human immunodeficiency virus (HIV) surrogate markers (CD4 counts) and plasma viral load. [2] Both infective (clinical or subclinical) and noninfective conditions can act as triggering factors for precipitating IRIS.
HISTORY OF IRIS
After the introduction of highly active antiretroviral therapy (HAART) in the mid-1990s, there were a lot
RISK FACTORS FOR IRIS
IRIS occurs more frequently in some patients or in some situations. These include: a CD4 count below 50 cells/ cmm prior to initiation of HAART, [7] a high viral load before initiation of therapy, [8] undetected presence of antigens of nonviable microorganisms (e.g., cryptococci and CMV), active or subclinical infection by opportunistic pathogens, initiation of ART in close proximity to the diagnosis and initiation of treatment for an OI, [9] use of cytokines such as IL-2 to treat HIV infection and genetic mutations of innate cytokines.
CRITERIA FOR DIAGNOSIS
Recently, French et al have laid down criteria so as to aid the diagnosis. [2] These are:
Major criteria 1. Atypical presentation of 'opportunistic infections inflammator y or infective pathology that is responsible for causing it [ 10 lymphomas, Castleman's disease copies/mL.
Infectious syndromes Minor criteria
Various infectious syndromes described in association Increased blood CD4 T-cell count after HAART.
with IRIS are mentioned in Table 1 . Increase in immune response specific to the relevant pathogen, e.g., DTH response to CLINICAL FEATURES OF SOME COMMON IRIS mycobacterial antigens.
Spontaneous resolution of disease without specific
The clinical manifestations of IRIS associated with antimicrobial therapy or tumor chemotherapy with some common OIs are elaborated below. continuation of antiretroviral therapy.
Tuberculosis and atypical mycobacterial MECHANISM OF IRIS infections [11, 12] Tuberculosis (TB) as IRIS typically occurs one to six Although the exact mechanism of IRIS is not weeks after the patient begins ART known, it may be due to immunologic symptoms of tuberculous IRIS may include high fever, consequences of HAART such as increase in CD4 new or worsening lymphadenopathy (mediastinal or cell levels, along with an elevated CD8 cell count peripheral), worsening of pulmonary symptoms and and an increased activity of cytokines like IL-2 and infiltrates or new or increasing pleural effusion. Lymph interferon-gamma. node abscesses usually occur during the first weeks on HAART. De Simone and his colleagues noted that a therapy. 2.
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. The signs and decrease in HIV viral load might alter levels of interleukin 12 (IL-12), a mediator of anticr yptococcal activity, resulting in meningitis symptoms. Guillaume Foulon and colleagues found that interleukin 2 (IL-2) and interferongamma appeared to be the important factors in two patients developing sarcoidosis as IRIS, as both cytokines are essential in the production of a granulomatous response. [10] 
PRESENTATIONS OF IRIS
The clinical features of IRIS differ according to the Extrapulmonary presentations may occur, including expanding central nervous system lesions, skin or visceral abscesses, osteomyelitis, nephritis, meningitis, hypercalcemia, hepatosplenomegaly, epididymo orchitis, psoas abscess and bowel perforation.
In one study, four out of five patients, who had clinically developed atypical mycobacterial infections after HAART and significant improvements in CD4 T cell levels, showed a significantly increased MACspecific T cell response in vitro, proving that this phenomenon is indeed caused by the unmasking of subclinical infections. Cryptococcal meningitis [13] prior history of CMV retinitis or in patients with no Cryptococcal IRIS is usually seen within one week to previous evidence of retinitis while CMV vitritis and 11 months after ART. In patients with or without uveitis are seen exclusively in people with previous previously diagnosed cr yptococcal meningitis, CMV retinitis infection who responded to ARV therapy. presentation of cryptococcal IRIS typically includes fever, headache, lymphadenitis and meningitis. In CMV vitritis typically will present with acute onset of cases of IRIS, the MRI usually shows choriomeningitis blurred vision and "floaters" caused by posterior with significant enhancement in the choroid plexus. segment inflammation. Ophthalmologic examination Cryptococcal antigen in the cerebrospinal fluid is reveals numerous inflammatory cells in the vitreous positive, although culture remains negative.
humor. Symptoms usually resolve in one month without specific treatment and without any lasting visual effects. 
Pneumocystis jiroveci pneumonia [14]
Immune reconstitution inflammatory syndrome may present as worsening pulmonary symptoms and high fever in patients who had been improving on PCP therapy or in patients with recent successful treatment of PCP. Chest X-ray may show worsening lung involvement and oxygen saturation or arterial blood gas measurements may show worsening hypoxia or alveolar-arterial oxygen gradient. PCP IRIS, in certain cases, may lead to fatal acute respiratory failure.
CMV [15] CMV retinitis may be seen either in patients with a CMV uveitis as IRIS may occur within months of ART initiation, but typically is a late complication; occurring about three years after patients begin ART. It often results in macular edema, epiretinal membrane formation and/or cataracts, which can lead to permanent vision loss and hence requires a high index of suspicion. Failure of ART can be ruled out with decrease in CD4 count, increase in viral load, along with clinical deterioration while active opportunistic infections can be ruled out by isolating the pathogens. The World Health Organization (WHO) made an important distinction between IRIS and clinical failure while on anti-HIV therapy. [16] occurrence of IRIS does not require any modification in the treatment of OIs. Maintenance treatment for OIs should not be changed and previously completed OI treatment (e.g., for tuberculosis) should not be reinitiated. Similarly, the dosages of chronic suppressive treatment for an OI should not be increased.
PREVENTION OF IRIS
"Clinical failure is defined as clinical disease Diagnosis of IRIS requires a high index of suspicion. progression with development of an opportunistic
Detailed clinical history should be taken in patients infection or malignancy when the drugs have been suspected to have IRIS, which includes the following: given sufficient time to induce a protective degree of Symptoms: fever, cough or any specific symptoms; immune restoration. This needs to be differentiated history of OIs: including recently diagnosed as well as from an immune reconstitution syndrome which can past OIs; treatment of OIs: date of initiation, duration be seen within the first several weeks after the of therapy, clinical response, adherence, defaulter, institution of therapy if a subclinical infection is resistance; ART initiation: date, regimen, adherence, present at baseline." [16] prior history of ART, toxicity, any drug interaction; CD4 count and HIV viral load prior to ART initiation.
TREATMENT OF IRIS
Look for the vital signs, including temperature, heart As of now, there are no standard guidelines for the rate, blood pressure and respiratory rate. Perform a treatment of IRIS and the following interventions are careful and thorough physical examination based on mostly based on published case reports and other symptoms and suspicion of systems involved. anecdotal clinical evidence. Treatment includes Ophthalmologic examination should be included in continuation of primary therapy against the offending all patients. pathogen in order to decrease the antigenic load, continuation of effective HAART and judicious use of
The following investigations should be considered anti-inflammatory agents. [17] before starting ART: Complete blood count with differential, ESR, serum electrolytes, liver function Milder IRIS: Continue HARRT, antimicrobial agents tests and renal function tests, CD4 count and HIV and nonsteroidal antiinflammatory drugs. viral load, chest X-ray, Mantoux (tuberculin) test, Severe life-threatening IRIS: Needs oral sputum stain and culture and ultrasonography of 1.
2.
prednisolone, approximately 1-2 mg/kg. The exact duration and dose of the steroid is variable and depends upon clinical severity. Sometimes the duration of the steroid therapy may extend to six months or one year. Consider discontinuation of HAART in case of severe life-threatening IRIS (e.g., encephalitis, ARDS, cerebritis and perilesional cerebral edema).
Patients with IRIS have almost invariably better outcomes than those who are HIV positive with clinical progression of a given disease. The abdomen. In a suspected case, even an initially negative Mantoux test becoming positive could be suggestive of IRIS.
Patients who are started on ART having CD4 count of less than 100 cells/µl require close clinical monitoring during the first weeks of ART. Similarly, they should be counseled about the risk of development of IRIS to avoid being discouraged and defaulting on therapy as development of IRIS suggests increase in the immunity and is a good sign unless life-threatening. 
